Abstract
Burkholderia cepacia is an opportunistic pathogen that causes severe systemic infections in patients with chronic granulomatous disease (CGD) or with cystic fibrosis (CF), but its mechanisms of virulence are poorly understood. We developed a murine model of systemic infection in wild-type (WT) and gamma interferon knockout (GKO) BALB/c mice to facilitate dissection of components of pathogenicity and host defense. Both WT and GKO mice were susceptible to chronic splenic infection with B. cepacia, but not with Pseudomonas aeruginosa. B. cepacia strains from patients with CGD persisted longer than those from CF patients. C57BL/6 mice were the most susceptible murine strain; bacteria persisted in the spleen for 2 months. DBA/2, BALB/c, and A/J strains of mice were relatively resistant to infection. Certain strains of B. cepacia complex can persist in the murine spleen after systemic infection; this may provide clues to its virulence in compromised hosts, such as those with CGD and CF.
MeSH Terms
Animals
Burkholderia Infections/immunology,pathology
Burkholderia cepacia/pathogenicity
Disease Models, Animal
Genotype
Interferon-gamma/pharmacology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred DBA
Species Specificity
Spleen/microbiology
Virulence
Chemicals
Interferon-gamma
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Speert D P
Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4. speert@unixg.ubc.ca
Steen B
Halsey K
Kwan E
References (27)
27 references, click to expand
-
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.
Mol Microbiol. 1996 Dec;22(5):991-1003
PMID: 8971719
-
Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice.
Infect Immun. 1995 May;63(5):1718-24
PMID: 7729877
-
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.
Infect Immun. 1997 Oct;65(10):4281-7
PMID: 9317038
-
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
Int J Syst Bacteriol. 1997 Oct;47(4):1188-200
PMID: 9336927
-
Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.
Infect Immun. 1998 Apr;66(4):1748-51
PMID: 9529107
-
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.
J Infect Dis. 1975 Jun;131(6):688-91
PMID: 805812
-
Genetic regulation of resistance to intracellular pathogens.
Nature. 1982 Jun 10;297(5866):506-9
PMID: 7045675
-
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
J Pediatr. 1984 Feb;104(2):206-10
PMID: 6420530
-
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).
Arch Biochem Biophys. 1988 Jan;260(1):493-6
PMID: 3124753
-
Interferon-gamma, the activated macrophage, and host defense against microbial challenge.
Ann Intern Med. 1988 Apr;108(4):595-608
PMID: 3126690
-
Simultaneous identification of bacterial virulence genes by negative selection.
Science. 1995 Jul 21;269(5222):400-3
PMID: 7618105
-
Role of interferon-gamma in immune cell regulation.
J Leukoc Biol. 1995 Oct;58(4):373-81
PMID: 7561512
-
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.
Nat Med. 1995 Jul;1(7):661-6
PMID: 7585148
-
Immunity to intracellular microbial pathogens.
Immunol Today. 1995 Jul;16(7):338-42
PMID: 7576070
-
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Microbiol Rev. 1996 Sep;60(3):539-74
PMID: 8840786
-
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.
Infect Immun. 1996 Oct;64(10):4054-9
PMID: 8926068
-
Purification and characterization of an extracellular protease from Pseudomonas cepacia.
Infect Immun. 1989 Mar;57(3):771-8
PMID: 2645209
-
Linkage analysis of the Bcg gene on mouse chromosome 1. Identification of a tightly linked marker.
J Immunol. 1989 Jun 15;142(12):4507-13
PMID: 2566635
-
A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.
N Engl J Med. 1991 Feb 21;324(8):509-16
PMID: 1846940
-
Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance.
Mol Microbiol. 1991 Mar;5(3):641-6
PMID: 2046549
-
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis.
Infect Immun. 1992 Apr;60(4):1434-40
PMID: 1372295
-
Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.
Chest. 1993 Feb;103(2):466-71
PMID: 7679347
-
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science. 1993 Mar 19;259(5102):1739-42
PMID: 8456300
-
Virulence factors of Burkholderia cepacia.
FEMS Immunol Med Microbiol. 1994 Feb;8(2):89-97
PMID: 7513590
-
Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression.
J Exp Med. 1994 Nov 1;180(5):1741-52
PMID: 7964458
-
Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.
J Infect Dis. 1994 Dec;170(6):1524-31
PMID: 7527826
-
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.
J Clin Microbiol. 1997 Apr;35(4):808-16
PMID: 9157133